A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The study compares the effectiveness of treatment options for weight management after discontinuing semaglutide and tirzepatide. The primary outcome is absolute and percentage weight change at 12-weeks.
Epistemonikos ID: 4cdde985a7f7a42953d5dd3cd579301152331f15
First added on: Oct 01, 2024